Macfarlane Group PLC
29 February 2000
MACFARLANE LABELS SECURES £8m DEAL WITH US BEAUTY CARE GIANT
Macfarlane Group PLC's Labels Division is pleased to report
that it has secured a new £8million contract to continue to
supply Bristol Myers Squibb, one of the largest beauty care
companies in the US over the next three years.
The new three-year deal, will involve production of labels
for a number of major brands, and comes after 13 years of
service from Macfarlane Labels, and establishes it as a
major labels supplier for all current and future Bristol
Myers Squibb projects.
For further information please contact
Neil Gibson, Beattie Media:
01698 787868
Graham Casey,
Chief Executive Macfarlane Group Labels Division:
01563 525151
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.